Related Experiment Videos
Preliminary clinical experience with the first dual chamber pacemaker defibrillator
T Lavergne1, J C Daubert, M Chauvin
1Hôpital Broussais, Paris, France.
Pacing and Clinical Electrophysiology : PACE
|January 1, 1997
Summary
Dual chamber pacemakers improve implantable cardioverter-defibrillator (ICD) arrhythmia detection. This study found improved specificity in diagnosing ventricular tachycardia (VT) and ventricular fibrillation (VF) without sacrificing sensitivity.
Area of Science:
- Cardiology
- Biomedical Engineering
- Electrophysiology
Background:
- Current implantable cardioverter-defibrillators (ICDs) exhibit limitations in the specificity of ventricular tachycardia (VT) detection.
- Inaccurate detection can lead to inappropriate shocks or missed life-threatening arrhythmias.
Purpose of the Study:
- To evaluate the diagnostic accuracy of a novel dual-chamber pacemaker defibrillator (ICD) system.
- To compare the device's arrhythmia detection capabilities against physician diagnoses.
Main Methods:
- A French multicenter study involving 18 patients implanted with the Defender 9001 ICD.
- Analysis of 176 tachycardia episodes recorded over a mean follow-up of 7.1 months.
- Comparison of device-detected tachyarrhythmias with physician diagnoses.
Main Results:
- The ICD correctly identified all 122 ventricular tachycardia/ventricular fibrillation (VT/VF) episodes.
- The device accurately diagnosed 51 out of 53 supraventricular tachyarrhythmias (SVTs).
- Two episodes of atrial fibrillation (AF) with rapid ventricular rates were misclassified as VT, and one episode had uncertain diagnosis.
Conclusions:
- Dual-chamber pacing in ICDs enhances diagnostic specificity for tachyarrhythmias.
- This improvement is achieved without compromising detection sensitivity.
- The dual-chamber system provides additional hemodynamic benefits alongside improved arrhythmia detection.